Figure 1 — The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy

Research Paper|Volume 15, Issue 19|pp. 10305–10329

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy

Back to articleFigure 1(1 of 10)

100%

Figure 1.The flowchart of this investigation. To integrate multiple datasets to explore the role of ICD in the TME of LUAD, and to construct a signature to predict the prognosis and immunotherapy of LUAD patients.